Multiplikator Forward P/S: ClearPoint Neuro Inc. (CLPT)
The forward EV/Revenue multiple for ClearPoint Neuro, Inc. (CLPT) reflects market expectations for B2B neuronavigation system sales. The current parameter stands at 6.00, which correlates with the company's role as the creator of the foundational ecosystem for precision neuro-oncology. Current deliveries of stereotactic equipment via biotech partnerships support the share price increase, while regulatory risks are already priced into the asset.
Ringkesan rincian data analitis clearpointneuro.com (CLPT)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal ClearPoint Neuro, Inc.|CLPT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal ClearPoint Neuro|CLPT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ClearPoint Neuro, Inc.|CLPT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan ClearPoint Neuro|Rasio cepet clearpointneuro.com
- rincian asil keuangan lan kelipatan valuasi:
CLPT - Penghasilan resik perusahaan|Bathi sing dikarepake ClearPoint Neuro, Inc.|CLPT - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi ClearPoint Neuro|CLPT - Pangali PEG|Pangali EV/EBITDA ClearPoint Neuro, Inc.|CLPT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan ClearPoint Neuro|CLPT - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan clearpointneuro.com|CLPT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep ClearPoint Neuro, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:CLPT (ClearPoint)
Forward P/S determines the market value of an asset relative to projected revenue, allowing an investor to assess the extent of overpayment for future cash flows. The future P/S dynamics of ClearPoint Neuro, Inc. (CLPT) reflect market expectations for the scaling of robotic neuronavigation systems, where an increasing ratio confirms capital's bet on the expansion of high-precision hardware complexes in neurosurgery.
Karo sapa ClearPoint Neuro, Inc. saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Xtant Medical|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|Rasio rega marang prakiraan pendapatan MODD|Multiplikator Forward P/S MYO|COCH - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|Multiplikator Forward P/S envveno.com NVNO|SINT - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan TNON (Tenon Medical Inc.)|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan AMIX (Autonomix Medical)|Rasio rega marang prakiraan pendapatan INVO Fertility Inc|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep bonebiologics.com BBLG|Multiplikator Forward P/S AXNX|Rasio kapitalisasi marang dodolan sing dikarepake BIOLASE Inc.|Rasio rega marang prakiraan pendapatan Dynatronics DYNT|FNA: Kapitalisasi marang prakiraan pendapatan|INVO: Multiplikator forward rega marang pendapatan
